The GM1 gangliosidoses, usually shortened to GM1, are gangliosidoses caused by mutation in the GLB1 gene resulting in a deficiency of beta-galactosidase...
10 KB (1,071 words) - 09:59, 2 June 2024
The GM2 gangliosidoses are a group of three related genetic disorders that result from a deficiency of the enzyme beta-hexosaminidase. This enzyme catalyzes...
12 KB (1,240 words) - 14:39, 22 June 2024
Portuguese Water Dog (section GM1 storage disease)
treated if necessary.[citation needed] GM1 storage disease, one of a family of conditions called GM1 gangliosidoses, is a recessive, genetic disorder that...
24 KB (2,954 words) - 01:14, 9 August 2024
Gangliosidosis (redirect from Gangliosidoses)
autosomal recessive and affect males and females equally. GM1 gangliosidoses - GM1 GM2 gangliosidoses - GM2 Sphingolipidoses#Overview Prayson, Richard A. (2012)...
2 KB (60 words) - 14:51, 4 October 2021
juvenile- or adult-onset forms. Gangliosides: Gangliosidosis GM1 gangliosidoses GM2 gangliosidoses Tay–Sachs disease Sandhoff disease GM2-gangliosidosis, AB...
10 KB (652 words) - 23:45, 13 August 2024
of the sphingolipidoses may be classified into either GM1 gangliosidoses or GM2 gangliosidoses. Tay–Sachs disease belongs to the latter. Other lipid storage...
6 KB (663 words) - 14:33, 27 October 2023
in sweat gland function due to GL3 deposits in the eccrine glands. GM1 gangliosidoses, characterized by abnormal lipid storage, leads to vacuolization in...
44 KB (4,611 words) - 06:47, 3 August 2024
associated with GM2 gangliosidoses such as Tay–Sachs disease. Ganglioside GM2 activator protein Sphingolipidoses Structures of GM1, GM2, GM3 gangliosides...
4 KB (115 words) - 17:41, 5 July 2023
disorders Gangliosidoses (including Tay–Sachs disease (E75.0-E75.1) - they are a subtype of sphingolipidoses Sphingolipidoses that are not gangliosidoses, including...
18 KB (1,819 words) - 05:23, 3 April 2024
Metabolic Storage Diseases:, Tay–Sachs disease Farber disease GM1 and GM2 gangliosidoses Metachromatic leukodystrophy Niemann–Pick disease Sandhoff disease...
4 KB (313 words) - 22:00, 16 March 2023
disease MeSH C18.452.100.100.435.825.300 – gangliosidoses MeSH C18.452.100.100.435.825.300.300 – gangliosidoses GM2 MeSH C18.452.100.100.435.825.300.300...
47 KB (4,274 words) - 16:49, 9 February 2024
treatment of Gaucher disease types 2 and 3, GM2 gangliosidoses including Tay-Sachs and Sandhoff disease, and GM1 gangliosidosis. Using computational analysis...
21 KB (2,404 words) - 19:43, 15 July 2024
(1999-10-08). "Biochemical consequences of mutations causing the GM2 gangliosidoses". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease....
10 KB (1,315 words) - 08:31, 18 August 2023
disease MeSH C16.320.565.150.435.825.300 – gangliosidoses MeSH C16.320.565.150.435.825.300.300 – gangliosidoses GM2 MeSH C16.320.565.150.435.825.300.300...
78 KB (6,496 words) - 05:23, 12 April 2022
MeSH C10.228.140.163.100.435.825.300 – gangliosidoses MeSH C10.228.140.163.100.435.825.300.300 – gangliosidoses gm2 MeSH C10.228.140.163.100.435.825.300...
109 KB (9,229 words) - 16:51, 9 February 2024